1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. Previous Advocacy Updates

Previous Advocacy Updates

  • January 10, 2023

    With a new year, there are several new laws and regulations now impacting pathologists and their practices.

  • January 24, 2023

    As the 118th Congress took office in January, Republicans hold a slight majority in the House, making for a new speaker and committee leadership. House Speaker Kevin McCarthy (R-CA) was sworn in on January 7 along with the rest of Congress.

  • December 20, 2022

    In its 2023 federal funding legislation, Congress mitigated next year’s scheduled Medicare cuts to physicians, delayed implementation of pending cuts to clinical laboratory fees, and included a bill championed by the CAP to ensure the nation is prepared for future pandemics. The legislation did not include some other measures which the CAP asked Congress to adopt.

  • December 14, 2022

    As Congress debates its year-end legislation for 2022, the CAP has laid out its priorities for inclusion in the year-end omnibus appropriations package.

  • December 6, 2022

    As Congress negotiates year-end legislation, the CAP is urging lawmakers to prevent scheduled Medicare cuts in 2023 and protect Medicare payment for clinical laboratory fees before December 31. The CAP is also actively advocating for policies that prepare the country for future pandemics and to protect provisions in legislation providing guardrails on the federal oversight of laboratory tests.

  • November 22, 2022

    The CAP strongly opposed the health insurer Highmark’s new credentialing requirements for next-generation sequencing testing that imposes independent third-party validation of NGS results and/or variants of uncertain significance interpretation.

  • November 15, 2022

    The CAP recently asked the Centers for Medicare & Medicaid Services to evaluate remote sign-out practices for pathologists after the public health emergency ends.

  • November 8, 2022

    In an advocacy win for the pathologists, the Centers for Medicare & Medicaid Services finalized the proper rank order of the clinical labor rates for histotechnologists and laboratory technicians in the final 2023 Medicare Physician Fee Schedule (PFS).

  • November 1, 2022

    Special Issue: On November 1, the Centers for Medicare & Medicaid Services released the 2023 Medicare payment regulations, including the final 2023 Medicare Fee Schedule and Quality Payment Program regulations.

  • November 1, 2022

    In response to a congressional request for information regarding the potential reform of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), the CAP provided feedback regarding pathologists’ experience in dealing with the current payment program and potential actions Congress could take to stabilize the Medicare payment system by reforming MACRA.

  • October 25, 2022

    In response to an outbreak of Ebola in East Africa, the US Centers for Disease Control and Prevention (CDC) released guidance for clinical laboratories for Ebola specimen collection in the United States on October 18.

  • October 18, 2022

    On September 28, CAP President-elect Donald Karcher, MD, FCAP, urged in public testimony to the Council of the DC to reconsider laboratory personnel licensure and additional statutory fixes in lieu of repeal within the personnel clean-up bill.

  • October 11, 2022

    During the CAP 22 Annual Meeting, CAP members gathered in person and virtually and participate in an informative Advocacy Town Hall.

  • October 4, 2022

    The Council of Medical Specialty Societies (CMSS), a coalition of 48 specialty societies, awarded the CAP $100,000 grant to study how to make pathology reports more patient-centered and understandable.

  • September 27, 2022

    CAP leaders met with the Food and Drug Administration (FDA) to discuss issues pathologists have encountered with the emergency use authorization (EUA) process during the COVID-19 pandemic, especially as it relates to some laboratories reporting delays in obtaining EUAs for SARS-CoV-2 laboratory-developed tests (LDTs).

  • September 20, 2022

    On September 13, House Reps. Ami Bera, MD (D-CA), and Larry Bucshon, MD, (R-IN) introduced bipartisan legislation that would alleviate Medicare cuts for all physicians. The Supporting Medicare Providers Act of 2022 (HR 8800) aims to lessen the upcoming Medicare reimbursement cuts in 2023 and provides guidance to improve the Medicare Payment system for physicians. The CAP has urged that Congress take action to mitigate Medicare reimbursement cuts, while preserving critical physician services for Medicare patients.

  • September 13, 2022

    On September 7, the Food and Drug Administration declared a public emergency requiring clinical laboratory tests for monkeypox to obtain emergency use authorization (EUA) before offering the test clinically.

  • August 30, 2022

    To maintain the highest standards in diagnostic medicine, the CAP opposed several changes to the Centers for Medicare & Medicaid Services (CMS) staffing qualifications recommendations in a proposed 2023 CLIA regulation.

  • August 23, 2022

    The Biden administration released the final surprise billing regulation, which follows a court decision that struck down an earlier policy related to the independent dispute resolution process.

  • August 16, 2022

    During an open call with laboratories on August 15, officials with the Food and Drug Administration (FDA) said laboratory-developed tests (LDTs) for monkeypox disease are under enforcement discretion and can be developed without notifying the FDA. The CAP attended the Laboratory Outreach Communication System call managed by the Centers for Disease Control and Prevention (CDC).

Analysis of Final 2020 Medicare Rule

Read the special report Right Arrow

Direct questions or comments to:



  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. Right Arrow
Viewing 1-20 of 353